Cytokinetics (CYTK) came out with a quarterly loss of $1.33 per share versus the Zacks Consensus Estimate of a loss of$1.16. This compares to loss of $1.38 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -14.66$1.03 per share when it actually produced a loss of $1.38, delivering a surprise of -33.98%. Over the last four quarters, the c ...